The Development in Neurogenetic Disabilites Lab at the University of Illinois at Urbana-Champaign is conducting a research study to learn about what skills support early language development.
About the Study
Who can participate?
Mothers and their sons or daughters ages 18- to 36-months with a diagnosis of full mutation Fragile X syndrome may be eligible to participate.
What will happen in the study?
If the individual qualifies and decides to be in this research study, they will participate in three visits over a one-year period. Due to COVID-19, the visits will be conducted virtually via a secure Zoom meeting, and questionnaires will be completed online.
The following is a list of some of the study procedures that will happen during the study:
- Structured, instructed play with toys by toddlers and their mothers.
- Assessment of the child’s language and cognitive abilities, including an interview with mothers about their child’s daily skills.
- Parent questionnaires about the family, the child’s language abilities, and parenting.
- Mothers will complete a receptive vocabulary test and be interviewed about their experiences.
What are the good things that can happen from this research?
You will contribute to a growing body of research looking at early language development in Fragile X syndrome that will support early intervention efforts.
What are the bad things that can happen from this research?
There are no anticipated risks beyond those that exist in daily life to either you or your child if you choose to participate in this study.
- We will be sure to provide frequent breaks throughout the assessment as needed, in order to ensure that your child does not become bored or frustrated.
- We will work with you to make sure you and your child are comfortable throughout the assessment.
- If your child becomes tired, stressed, or otherwise unable to complete all of the activities, the session will be ended, and your child will be assured that this OK.
There may be other risks that we do not know about yet.
Will I/my child be paid to complete this survey?
Participants receive a $30 Amazon gift card for each visit. No travel or study expenses will be incurred by families.
Our Most Recent Opportunities
Study: Single Dose Study for Adult Women and Men with FXS
Dr. Craig Erickson at Cincinnati Children’s Hospital Medical Center is conducting a clinical trial to learn about if medication can change the brain’s response to sound, which may be abnormal in FXS.
Project WellCAST: Caregivers of Children with Fragile X Needed for a Research Study
The Kelleher Lab at Purdue University is conducting an NIH-funded clinical trial called Project WellCAST. Project WellCAST aims to understand how to best support caregivers of children with rare neurogenetic conditions, including Fragile X syndrome.
Study: Language, executive function, and quality of life of those with the Fragile X premutation
Researchers at the Waisman Center at UW-Madison are recruiting adults with the Fragile X premutation for a study on language, executive function, and quality of life.
Views and Experiences of Caregiver Coaching in Early Childhood Speech-Language Services: A Survey of Caregivers and Speech-Language Pathologists
The Research in Developmental Disabilities and Language Lab at The University of Wisconsin-Madison is conducting a survey to learn about you and your child’s experiences in speech therapy during early childhood.
Study: Behavioural and Emotional Outcomes in individuals with Neurodevelopmental Disorders (BEOND)
The Cerebra Network for Neurodevelopmental Disorders is conducting a survey to learn more about behaviour, social functioning, sleep, hyperactivity, mood, physical and mental health, as well as family functioning and wellbeing, and how these change over time.
Developing the Fragile X Syndrome-Health Index (FXS-HI): A Caregiver-Reported Outcome Measure
The Center of Health and Technology’s (CheT) Outcomes Division is conducting caregiver interviews to learn about and determine the most important symptoms to individuals with FXS to create an outcome measure for FXS.